Interestingly, Lefere et al. reported that serum VCAM-1 levels predicted hepatic fibrosis in patients with NAFLD, indicating a potential role of VCAM-1 in the fibrotic pathogenesis of NASH [22]. The gene discussed is VCAM1; the disease is metabolic dysfunction-associated steatohepatitis.